Theme: The Impact of Science in the Covid-19 Era
Guest Speaker: Prof. Babatunde Lawal Salako – Director General, Nigerian Institute of Medical Research, Yaba;
Chief Host: Prof. Jeremiah Oludele Ojediran – Vice-Chancellor, Bells University of Technology;
Host: Dr. Augustine Omoike – Ag. Dean, COLNAS
[CcHUB & Facebook] 2021 Sub-Saharan African Facebook Community Accelerator Digital Healthcare Training Program for members of the Naija Nurses Forum (NNF) facilitated by NIMR Digital Health/Telemedicine Team led by Dr. Amoo Olufemi Samuel
The DG and Management (NIMR) are grateful to Shell Nigeria Exploration and Production Company (SNEPCO) for supporting research by donating equipment for molecular techniques to the Centre for Infectious Disease Research (CIDR), Microbiology Department, NIMR facilitated by Dr Adetoun Mustapha (CIDR Adjunct).
On the 26th – 27th January, 2022, the laboratories at the Centre for Human Virology and Genomics (CHVG) and Centre for Tuberculosis Research (CTBR), both in Microbiology Department, were successfully re-assessed for ISO 15189 accreditation. Both centers have accredited assays in the field of molecular biology, serology, chemistry, heamatology and microbiology.
These laboratories have consistently expanded the number of assays accredited from the initial 13 assays in 2017 to 16 in 2019 and with this recent success, the number of assays accredited has been further increased to include “LJ Culture and Sensitivity” for diagnosis of tuberculosis. This brings the current number of accredited assays in both centers to 17.
The leadership of the institute appreciates the efforts of all members of staff who have worked tirelessly to make this happen. Bravo, keep the quality flag flying!!!
The ISO 15189 accreditation is highly regarded both nationally and internationally as a reliable indicator of technical competence for medical laboratories.
NIMR in collaboration with Afe Babalola University, Ado Ekiti (ABUAD) is evaluating the safety and efficacy of Virucidine, a Nigerian herbal medicine for management of COVID-19. Participants’ recruitment starts in the last week of February 2022.
Interested adults diagnosed with COVID-19 who want to participate in the study can contact the study focal person on
08033220631
nkiru_d@yahoo.com for further details.
